Adrenomedullin improves intestinal epithelial barrier function by downregulating Myosin light chain phosphorylation in ulcerative colitis rats

Molecular Medicine Reports

Volumn 12, Issue 3, 2015, Pages 3615-3620

  Yi, Zaifeng ^a   Fan, Heng ^a   Liu, Xingxing ^a   Tang, Qing ^a   Zuo, Dongmei ^a   Yang, Jia ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Adrenomedullin; Cytokine; Myosin light chain; Myosin light chain kinase; Ulcerative colitis

Indexed keywords

ADRENOMEDULLIN; INTERLEUKIN 6; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN KINASE; PROTEIN ZO1; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; ANTIHYPERTENSIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TIGHT JUNCTION; TRANSMISSION ELECTRON MICROSCOPY; ULCERATIVE COLITIS; WESTERN BLOTTING; ANIMAL; BLOOD; COLITIS, ULCERATIVE; DRUG EFFECTS; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SPRAGUE DAWLEY RAT;

RATTUS;

ADRENOMEDULLIN; ANIMALS; ANTIHYPERTENSIVE AGENTS; COLITIS, ULCERATIVE; INTERLEUKIN-6; INTESTINAL MUCOSA; MALE; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84935512394     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3887     Document Type: Article

References (35)

1. Turner JR: Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9:799-809, 2009.
2. Marchiando AM, Graham WV and Turner JR: Epithelial barriers in homeostasis and disease. Annu Rev Pathol 5:119-144, 2010.
3. Munkholm P, Langholz E, Hollander D, Thornberg K, Orholm M, Katz KD and Binder V: Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives. Gut 35:68-72, 1994.
4. Ashizuka S, Inagaki-Ohara K, Kuwasako K, Kato J, Inatsu H and Kitamura K: Adrenomedullin treatment reduces intestinal inflammation and maintains epithelial barrier function in mice administered dextran sulphate sodium. Microbiol Immunol 53:573-581, 2009.
5. Gardiner KR, Anderson NH, Rowlands BJ and Barbul A: Colitis and colonic mucosal barrier dysfunction. Gut 37:530-535, 1995.
6. Clayburgh DR, Shen L and Turner JR: A porous defense: The leaky epithelial barrier in intestinal disease. Lab Invest 84:282-291, 2004.
7. Gibson PR: Increased gut permeability in Crohn's disease: Is TNF the link? Gut 53:1724-1725, 2004.
8. Nusrat A, Turner JR and Madara JL: Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: Nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol 279:G851-G857, 2000.
9. Ye D, Ma I and Ma TY: Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 290:G496-G504, 2006.
10. Gu L, Li N, Gong J, Li Q, Zhu W and Li J: Berberine ameliorates intestinal epithelial tight-junction damage and down-regulates myosin light chain kinase pathways in a mouse model of endotoxinemia. J Infect Dis 203:1602-1612, 2011.
11. Costantini T W, Loomis WH, Putnam JG, et al: Pentoxifylline modulates intestinal tight junction signaling after burn injury: Effects on myosin light chain kinase. J Trauma 66:17-24; discussion 24-25, 2009.
12. Shen L: Tight junctions on the move: Molecular mechanisms for epithelial barrier regulation. Ann NY Acad Sci 1258:9-18, 2012.
13. Liu X, Xu J, Mei Q, Han L and Huang J: Myosin light chain kinase inhibitor inhibits dextran sulfate sodium-induced colitis in mice. Dig Dis Sci 58:107-114, 2013.
14. Elsasser TH and Kahl S: Adrenomedullin has multiple roles in disease stress: Development and remission of the inflammatory response. Microsc Res Tech 57:120-129, 2002.
15. Sakata J, Asada Y, Shimokubo T, Kitani M, Inatsu H, Kitamura K, Kangawa K, Matsuo H, Sumiyoshi A and Eto T:: Adrenomedullin in the gastrointestinal tract. Distribution and gene expression in rat and augmented gastric adrenomedullin after fasting. J Gastroenterol 33:828-834, 1998.
16. Ashizuka S, Ishikawa N, Kato J, Yamaga J, Inatsu H, Eto T and Kitamura K: Effect of adrenomedullin administration on acetic acid-induced colitis in rats. Peptides 26:2610-2615, 2005.
17. Kataoka Y, Miyazaki S, Yasuda S, Nagaya N, Noguchi T, Yamada N, Morii I, Kawamura A, Doi K, Miyatake K, et al:: The first clinical pilot study of intravenous adrenomedullin administration in patients with acute myocardial infarction. J Cardiovasc Pharmacol 56:413-419, 2010.
18. Gonzalez-Rey E, Fernandez-Martin A, Chorny A and Delgado M: Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn's disease. Gut 55:824-832, 2006.
19. Talero E, Alvarez de Sotomayor M, Sánchez-Fidalgo S and Motilva V: Vascular contribution of adrenomedullin to microcirculatory improvement in experimental colitis. Eur J Pharmacol 670:601-607, 2 011.
20. Hayashi Y, Narumi K, Tsuji S, Tsubokawa T, Nakaya MA, Wakayama T, Zuka M, Ohshima T, Yamagishi M and Okada T:: Impact of adrenomedullin on dextran sulfate sodium-induced inflammatory colitis in mice: Insights from in vitro and in vivo experimental studies. Int J Colorectal Dis 26:1453-1462, 2011.
21. Carrizo GJ, Wu R, Cui X, Dwivedi AJ, Simms HH and Wang P: Adrenomedullin and adrenomedullin-binding protein-1 downregulate inflammatory cytokines and attenuate tissue injury after gut ischemia-reperfusion. Surgery 141:245-253, 2007.
22. Zuo D, Liu X, Shou Z, Fan H, Tang Q, Duan X, Cao D, Zou Z and Zhang L: Study on the interactions between transplanted bone marrow-derived mesenchymal stem cells and regulatory T cells for the treatment of experimental colitis. Int J Mol Med 32:1337-1344, 2013.
23. Li X, Wang Q, Xu H, Tao L, Lu J, Cai L and Wang C: Somatostatin regulates tight junction proteins expression in colitis mice. Int J Clin Exp Pathol 7:2153-2162, 2014.
24. Greig E and Sandle GI: Diarrhea in ulcerative colitis. The role of altered colonic sodium transport. Ann NY Acad Sci 915:327-332, 2000.
25. Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ, Riecken EO and Schulzke JD: Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 116:301-309, 1999.
26. Fischer A, Gluth M, Pape UF, Wiedenmann B, Theuring F and Baumgart DC: Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 304:G970-G979, 2013.
27. Ma TY, Boivin MA, Ye D, Pedram A and Said HM: Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: Role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol 288:G422-G430, 2005.
28. Marchiando AM, Shen L, Graham W V, Weber CR, Schwarz BT, Austin JR 2nd, Raleigh DR, Guan Y, Watson AJ, Montrose MH, et al:: Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J Cell Biol 189:111-126, 2010.
29. Sommer J, Engelowski E, Baran P, Garbers C, Floss DM and Scheller J: Interleukin-6, but not the interleukin-6 receptor plays a role in recovery from dextran sodium sulfate-induced colitis. Int J Mol Med 34:651-660, 2014.
30. Irvine EJ and Marshall JK: Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology 119:1740-1744, 2000.
31. Wyatt J, Vogelsang H, Hübl W, Waldhöer T and Lochs H: Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 341:1437-1439, 1993.
32. Wang F, Graham W V, Wang Y, Witkowski ED, Schwarz BT and Turner JR: Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 166:409-419, 2005.
33. Taylor CT, Dzus AL and Colgan SP: Autocrine regulation of epithelial permeability by hypoxia: Role for polarized release of tumor necrosis factor alpha. Gastroenterology 114:657-668, 1998.
34. Ueda S, Nishio K, Minamino N, Kubo A, Akai Y, Kangawa K, Matsuo H, Fujimura Y, Yoshioka A, Masui K, et al:: Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome. Am J Respir Crit Care Med 160:132-136, 1999.
35. Higuchi S, Wu R, Zhou M, Marini C P, Ravikumar TS and Wang P: Gut hyperpermeability after ischemia and reperfusion: Attenuation with adrenomedullin and its binding protein treatment. Int J Clin Exp Pathol 1:409-418, 2008.